Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

THE UNITED STATES PHARMACOPEIAL CONVENTION

A. D. Hirschfelder · JAMA · 1930 · 1K citations

Pharmacy, Pharmaceutical Policy, Drug Law +8

Transport and Deposition of Micro-Aerosols in Realistic and Simplified Models of the Oral Airway

Jinxiang Xi, P. Worth Longest · Annals of Biomedical Engineering · 2007 · 275 citations

Pharmacy, Oral Biology, Oral Anatomy +11

Validation of a General <i>In Vitro</i> Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products

Bo Olsson, Lars Borgström, Hans Lundbäck et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2013 · 133 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

<i>In Vivo–In Vitro</i> Comparison of Deposition in Three Mouth–Throat Models with Qvar ^® and Turbuhaler ^® Inhalers

Yu Zhang, Kyle Gilbertson, Warren H. Finlay · Journal of Aerosol Medicine · 2007 · 109 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Pharmacokinetic/Pharmacodynamic Aspects of Aerosol Therapy using Glucocorticoids as a Model

Günther Hochhaus, H Möllmann, Hartmut Derendorf et al. · The Journal of Clinical Pharmacology · 1997 · 103 citations

Pharmacy, Pharmacokinetics, Pharmacology +17